Closing the Gender Health Gap: Driving Accountability through the [w]Health Index
September 30, 2025
11:00 AM – 12:00 PM
Join Kearney in discussion of how today’s women face a number of disadvantages in healthcare, from a lack of funding and research into female diseases to drugs and devices being tested and designed for the male anatomy.
Presented by A.T. Kearney
Closing the Gender Health Gap: Driving Accountability through the [w]Health Index
September 30, 2025
11:00 AM – 12:00 PM
Closing the Gender Health Gap: Driving Accountability through the [w]Health Index
September 30, 2025
11:00 AM – 12:00 PM
Join Kearney in discussion of how today’s women face a number of disadvantages in healthcare, from a lack of funding and research into female diseases to drugs and devices being tested and designed for the male anatomy. The experience of care provided in this unequal healthcare system is leaving women feeling sidelined and inadequately supported. The [w]Health Index is a new tool which aims to support organizations in taking action to advance the health of women and drive accountability by assessing current activities, comparing against peers, and learning from best practices, which also enables better health and business outcomes.
Join this session to learn more about our preliminary findings of the [w]Health MedTech Index and hear from industry leaders about what they’re doing to start taking action to redesign healthcare with women in mind and close the gender health gap.
Date: September 30th, 2025
Time: 11:00 AM -12:00 PM ET
Location: Online
RSVP now to stay ahead of the curve and uncover what’s next for MedTech in today’s dynamic healthcare landscape.
Meet The Speakers
Paula Bellostas Muguerza – Senior Partner and Global Lead Healthcare and Life Sciences, Kearney
Paula Bellostas Muguerza is a partner and global lead for Kearney’s Healthcare and Life Sciences practice. She works with leading global biopharmaceutical companies on commercial strategy and transformation and has a passion for exploring the opportunity to improve patient outcomes at the intersection of medicine and technology. With her life motto of “Work hard, be kind, and good things will happen,” combined with the DNA from a family of serial entrepreneurs, Paula is always looking for new ways of making an impact––in and outside the firm. Recently, together with a passionate “village” of women and allies, she founded and leads [w]Health, a global platform of 450+ companies with the mission of advancing women’s health worldwide.
Sofiat Akinola – Director Health and Policy, Roche
Sofiat Akinola is the Director of Health Policy and External Affairs at Roche Diagnostics. In this role, she leads global efforts to engage with policy stakeholders in advocating for timely access to screening and diagnostic solutions that improve patient outcomes and support stronger health systems. Her work focuses on women’s health, including cervical cancer, and informing policies that advance better health for all.
Carla Goulart Peron, MD – Chief Medical Officer, Royal Philips
Carla Goulart Peron, MD, is the Chief Medical Officer of Royal Philips and leads a global team of medical and scientific experts working within and across Philips’ businesses. Carla and her team design and implement the company’s medical strategy and provide medical oversight and thought leadership across the company. Their collective role is to help drive meaningful innovation through excellence in medical safety, medical affairs, health economics, and clinical research. A physician with over 15 years of experience in medical device and pharmaceutical industry leadership positions, Carla combines her strong clinical background with executive experience, and a hands-on approach to lead highly engaged teams with a reputation for complex problem solving, critical thinking, and collaboration. She is passionate about innovating to improve access to care.
